# Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy

> **NCT06495008** · — · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 101 (actual)

## Conditions studied

- Melanoma
- Non-small Cell Lung Cancer (NSCLC)
- Urogenital Cancers

## Interventions

- **OTHER:** no intervention, only questionnaires, saliva collection and taste/smell tests

## Key facts

- **NCT ID:** NCT06495008
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-26
- **Primary completion:** 2025-02-11
- **Final completion:** 2025-02-11
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2025-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06495008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06495008, "Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06495008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*